New Delhi: Bharat Biotech's coronavirus vaccine Covaxin has been found to be well-tolerated and produced an immune response, says the Phase-1 interim data published by the company in the peer-reviewed ...
New Delhi: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine Covaxin. Out of this, it will supply ...
New Delhi: Covaxin manufacturer Bharat Biotech has warned people who are immuno-compromised or are on medicines that affect the immune system to not take the jab, according to a detailed ...
Mumbai: The debate over Bharat Biotech-manufactured Covaxin continues. A writ plea has been moved before the Bombay High Court seeking direction to the Drugs Controller General of India (DCGI) to ...
New Delhi: Those receiving Bharat BioTech’s Covaxin during the nationwide vaccination drive against COVID-19 will have to sign a “consent form” and agree to certain terms and conditions. Besides, the ...
New Delhi: Amid criticism of what many consider to be ‘premature’ emergency use approval given to Bharat Biotech’s Covaxin, a senior scientist of Indian Council of Medical Research (ICMR) vouched ...
New Delhi: Following reports of a volunteer’s demise during its Phase 3 vaccine trials, Bharat Biotech on Saturday cited cardio respiratory failure due to suspected poisoning as the probable cause ...
Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute's Covishield. Covishield will be sold at Rs 200 per vial to the ...
New Delhi: The logistics for storing all Indian vaccines being developed against the coronavirus at 2-8 degrees Celsius have been worked out while considering temperature as a factor, 'mint' quoted ...
New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed confidence at a press conference on Monday. According to Bharat ...
Copyright © 2024 Frontier Media
